American Heart Journal
Volume 151, Issue 3 , Pages 580-588 , March 2006

Interpretation of subgroup results in clinical trial publications: Insights from a survey of medical specialists in Ontario, Canada

  • Andrea B. Parker, MSc, PhD

      Affiliations

    • Cardiac Research Inc., Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Andrea B. Parker, MSc, PhD, Cardiac Research Inc, 15 Oakley Place, Toronto, Ontario, Canada M2P 2G3.
    • ,
  • C. David Naylor, MD, DPhil

      Affiliations

    • Department of Medicine and Office of the Dean, Faculty of Medicine, University of Toronto, Ontario Canada

Received 6 January 2005 ,Accepted 6 May 2005.

References 

  1. Rothwell PM. Can overall results of clinical trials be applied to all patients?. Lancet. 1995;345:1616–1619
  2. Rothwell PM. What do the overall results of clinical trials and meta-analyses tell us about the efficacy of treatments?. J Nephrol. 1997;10:5–6
  3. Glasziou PP, Irwig LM. An evidence based approach to individualising treatment. BMJ. 1995;311:1356–1359
  4. Lubsen J, Tijssen JG. Large trials with simple protocols: indications and contraindications. Control Clin Trials. 1989;10(4 Suppl):151S–160S
  5. Altman DG. Within trial variation—a false trail?. J Clin Epidemiol. 1998;51:301–303
  6. Bulpitt CJ. Subgroup analysis. Lancet. 1988;2:31–34
  7. Buyse ME. Analysis of clinical trial outcomes: some comments on subgroup analyses. Control Clin Trials. 1989;10(4 Suppl):187S–194S
  8. Byar DP. Assessing apparent treatment-covariate interactions in randomized clinical trials. Stat Med. 1985;4:255–263
  9. Collins R, Gray R, Godwin J, et al. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med. 1987;6:245–250
  10. Feinstein AR. The problem of cogent subgroups: a clinicostatistical tragedy. J Clin Epidemiol. 1998;51:297–299
  11. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1998;41:361–372
  12. Gheorghiade M, Schultz L, Tilley B, et al. Subgroup analysis of clinical trials. Am J Cardiol. 1991;67:330–332
  13. Horowitz R, Singer B, Makuch RW, et al. On reaching the tunnel at the end of the light. J Clin Epidemiol. 1997;50:753–755
  14. Horowitz R, Singer B, Makuch RW, et al. Clinical versus statistical considerations in the design and analysis of clinical research. J Clin Epidemiol. 1998;51:305–307
  15. Horwitz RI, Singer BH, Makuch RW, et al. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol. 1996;49:395–400
  16. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78–84
  17. Peto R. Treatment of cancer. London: Chapman and Hall; 1982;
  18. Rockette HE, Caplan RJ. Strategies for subgroup analysis in clinical trials. Recent Results Cancer Res. 1988;111:49–54
  19. Schneider B. Analysis of clinical trial outcomes: alternative approaches to subgroup analysis. Control Clin Trials. 1989;10(4 Suppl):176S–186S
  20. Senn S, Harrell F. On wisdom after the event. J Clin Epidemiol. 1997;50:749–751
  21. Simon R. Patient subsets and variation in therapeutic efficacy. Br J Pharmacol. 1982;14:482
  22. Stallones RA. The use and abuse of subgroup analysis in epidemiological research. Prev Med. 1987;16:183–194
  23. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991;266:93–98
  24. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145–153
  25. Parker AB, Naylor CD. Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials. Am Heart J. 2000;2000:952–961
  26. Warwick D, Lininger C. Survey design. The sample survey: theory and practice. New York: McGraw-Hill; 1975;
  27. Aday LA. In: Deciding how many will be in the sample. Designing and conducting health surveys: a comprehensive guide. San Francisco: Jossey-Bass; 1996;p. 143–176
  28. Redelmeier DA, Tversky A. Discrepancy between medical decisions for individual patients and for groups. N Engl J Med. 1990;322:1162–1164
  29. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129–1136
  30. McAvoy BR, Kaner EF. General practice postal surveys: a questionnaire too far?. BMJ. 1996;313:732–733
  31. Jones TV, Gerrity MS, Earp J. Written case simulations: do they predict physician's behavior?. J Clin Epidemiol. 1990;43:805–815

PII: S0002-8703(05)00488-6

doi: 10.1016/j.ahj.2005.05.002

American Heart Journal
Volume 151, Issue 3 , Pages 580-588 , March 2006

Article Tools

* Image Usage & Resolution